Jove
Visualize
联系我们

相关概念视频

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

277
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
277
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

446
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
446
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
274
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

640
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
640
Seizures: Classification01:13

Seizures: Classification

586
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
586
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

615
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
615
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策
  1. 首页
  2. 在治疗的患者中出现过度症状的亚临床甲状腺功能低下症:病例报告
  1. 首页
  2. 在治疗的患者中出现过度症状的亚临床甲状腺功能低下症:病例报告

相关实验视频

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

20.5K

在治疗的患者中出现过度症状的亚临床甲状腺功能低下症:病例报告

Samarth Doshi1, Kelly A Denhard2, Kathryn Li Xixis3

  • 1Department of Pediatrics, Northwestern University's Feinberg School of Medicine and The Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Journal of child neurology
|August 20, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

瓦尔酸治疗可能导致临床下甲状腺功能低下. 这一病例突出显示了一名儿童患者出现明显的甲状腺功能低下症状, 证明了氨酸的罕见但可能的不良影响.

关键词:
抗药物抗发作药物发生亚临床甲状腺功能低下症瓦尔酸

更多相关视频

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.8K
Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

3.4K

相关实验视频

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

20.5K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.8K
Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

3.4K

科学领域:

  • 儿童内分泌学
  • 神经学
  • 药理学

背景情况:

  • 瓦尔酸与激素功能障碍有关,包括可能与亚临床甲状腺功能障碍有关.
  • 现有文献讨论了这种关联,大多数研究没有报告明显的甲状腺功能低下症状与亚临床甲状腺功能低下症.

研究的目的:

  • 在长期治疗中出现儿科普遍性,患有明显症状的亚临床甲状腺功能低下症.
  • 突出表现出罕见的症状性亚临床甲状腺功能低下症作为氨酸的不良反应.

主要方法:

  • 一个3岁的儿科患者的病例报告,患有缺席,单独接受了酸治疗.
  • 在两年治疗期间监测甲状腺功能和临床症状.
  • 在症状和实验室结果的基础上诊断二级临床甲状腺功能低下症.

主要成果:

  • 经过两年多的治疗,该患者出现了明显的甲状腺功能低下症状.
  • 确诊了2级的临床下甲状腺功能低下症.
  • 症状在停止使用瓦尔酸盐并开始使用levothyroxine时消失.

结论:

  • 亚临床甲状腺功能低下是一种已知的瓦尔酸的不良反应.
  • 这一案例突显出显著的甲状腺功能低下症状,尽管很少见,但在接受氨酸治疗的儿童患者中可能会表现出来.
  • 治疗包括停止使用氨酸和使用levothyroxine,导致甲状腺功能正常化和症状消失.